Tag: NIH
-
U.S. Supports Home Smartphone Covid-19 Test
The U.S. government is funding large-scale production of Covid-19 home test kits that send results to the user’s smartphone.
-
Antibody Therapy Shown to Prevent Covid-19 Disease
Clinical trial results show a combination of synthetic antibodies designed to treat Covid-19 infections can also prevent contracting the disease.
-
Covid-19 Vaccine Shown Active Against Variants
Moderna Inc., developer of a vaccine to prevent Covid-19 disease, says lab test results show antibodies from the vaccine neutralize two recently found viral mutations.
-
U.S. Rejoins WHO, Participates in Int’l Vaccine Project
In one of its first actions, the Biden administration rejoined the United States in the World Health Organization, reversing a policy of its predecessor.
-
Antibodies Prevent Covid-19 Symptoms in Long-Term Care
A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower risk of getting symptomatic Covid-19 infections.
-
Multi-Variant Covid-19 Vaccine in the Works
A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical trial expected to begin soon.
-
Moderna Developing Flu, HIV, Nipah Vaccines
Moderna Inc., developer of a currently authorized Covid-19 vaccine, is expanding its vaccine pipeline to cover three more common infectious viral diseases.
-
Small Biz Grant Funds Heat-Stable Multi-Virus Vaccine
A biotechnology company is receiving a federal grant for a vaccine in freeze-dried form to prevent infections from Covid-19 and Ebola viruses.
-
Large Trial Testing Covid-19 Antibody Therapies
A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections.
-
Covid-19 Antibody Developer Raises $483M in IPO
A biotechnology company developing therapeutic antibodies for Covid-19 infections is raising $483 million in its initial public offering of common stock.